Literature DB >> 26075373

A randomised study of NPWT closure versus alginate dressings in peri-vascular groin infections: quality of life, pain and cost.

C Monsen1, S Acosta1, K Mani2, C Wann-Hansson3.   

Abstract

OBJECTIVE: The aim of this study was to compare the vacuum assisted wound closure (VAC) system (negative pressure wound therapy; NPWT) and alginate wound dressings in terms of quality of life (QoL), pain resource use and cost in patients with deep peri-vascular groin infection after vascular surgery.
METHOD: Patients with deep peri-vascular groin infection (Szilagyi grade III) were included and randomised to NPWT or alginate therapy. EuroQol 5D (EQ-5D) and brief pain inventory (BPI) were used to evaluate QoL and pain, respectively.
RESULTS: Wound healing time until complete skin epithelialisation was shorter in the NPWT (n=9) compared to the alginate group (n=7), median 57 and 104 days, respectively (p=0.026). No difference was recorded in QoL and pain between the groups at study start and the second assessment. QoL analysis within groups between time points, showed that patients in NPWT groups improved in EQ-5D domains, 'self-care' (p= 0.034), 'usual activities' (p=0.046); EQ-5D index value (p=0.046) and EQ-VAS (p=0.028). Patients in the NPWT group reported significantly less pain 'affecting their relations with other people' and 'sleep' between time points. The NPWT group had significantly fewer dressing changes compared to the alginate group (p<0.001). The median frequency of wound dressing changes outside hospital was 20 (IQR 6-29) in the NPWT group (n=9), compared to 48 (IQR 42-77) in the alginate group (n=8; p=0.004). The saved personnel time for wound care in the first week for the NPWT group, compared with the alginate group, was 4.5 hours per week per nurse. The total hospitalised care cost was 83-87% of the total cost in both groups.
CONCLUSION: NPWT therapy in patients with deep peri-vascular groin infection can be regarded as the dominant strategy due to improved clinical outcome with equal cost and quality of life measures.

Entities:  

Keywords:  cost; groin infection; negative wound pressure therapy; pain; quality of life

Mesh:

Substances:

Year:  2015        PMID: 26075373     DOI: 10.12968/jowc.2015.24.6.252

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  6 in total

1.  Ten-year analyses of the German DRG data about negative pressure wound therapy.

Authors:  Olga von Beckerath; Alexander Zapenko; Joachim Dissemond; Knut Kröger
Journal:  Int Wound J       Date:  2016-07-04       Impact factor: 3.315

2.  Prosthetic Vascular Graft Infections: Bacterial Cultures from Negative-Pressure-Wound-Therapy Foams Do Not Improve Diagnostics.

Authors:  Alexandra U Scherrer; Guido Bloemberg; Reinhard Zbinden; Annelies S Zinkernagel; Claudio Fuchs; Sandra Frauenfelder; Zoran Rancic; Dieter Mayer; Barbara Hasse
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

3.  Hospitalised patients' experiences during Negative Pressure Wound Therapy due to surgical site infection after vascular and cardiac surgery.

Authors:  Charlotte B Thorup; Mette Hougaard; Pernille F Blindum; Erik E Sørensen
Journal:  Int Wound J       Date:  2018-06-21       Impact factor: 3.315

Review 4.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; Chunhu Shi; En Lin Goh; Elizabeth Ma Murphy; Adam Reid; Laura Chiverton; Monica Stankiewicz; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2022-04-26

5.  Negative pressure wound therapy in patients with wounds healing by secondary intention: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Yvonne Zens; Michael Barth; Heiner C Bucher; Katrin Dreck; Moritz Felsch; Wolfram Groß; Thomas Jaschinski; Heike Kölsch; Mandy Kromp; Inga Overesch; Stefan Sauerland; Sven Gregor
Journal:  Syst Rev       Date:  2020-10-10

6.  Negative Pressure Wound Therapy vs Conventional Wound Treatment in Subcutaneous Abdominal Wound Healing Impairment: The SAWHI Randomized Clinical Trial.

Authors:  Dörthe Seidel; Stephan Diedrich; Florian Herrle; Henryk Thielemann; Frank Marusch; Rebekka Schirren; Recca Talaulicar; Tobias Gehrig; Nadja Lehwald-Tywuschik; Matthias Glanemann; Jörg Bunse; Martin Hüttemann; Chris Braumann; Oleg Heizmann; Marc Miserez; Thomas Krönert; Stephan Gretschel; Rolf Lefering
Journal:  JAMA Surg       Date:  2020-06-01       Impact factor: 14.766

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.